Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

As The Hive Evolves, More Companies Prepare to Join the Program

Posted on December 11th, 2017 by in Pharma R&D

This year, four companies working in early-stage drug development were able to power their efforts with an array of Elsevier tools by participating in The Hive. Now, more promising pharma and biotech start-ups are in the process of entering into The Hive Continue reading “As The Hive Evolves, More Companies Prepare to Join the Program” »

Seeking Other Perspectives to Tease Out New Innovations

Posted on November 22nd, 2017 by in Pharma R&D

On October 24, Astellas Oncology announced the five finalists in its C3 Prize competition, chosen from over 160 entrants who submitted their ideas on how to improve the cancer care experience through non-medicine innovations. Continue reading “Seeking Other Perspectives to Tease Out New Innovations” »

As Drug Development Costs Skyrocket, AI Offers Some Hope

Posted on November 20th, 2017 by in Pharma R&D

Last year, researchers from the Tufts Center for the Study of Drug Development published a paper in the Journal of Health Economics that provided an assessment of the current cost for pharmaceutical companies to discover and develop new drugs and biologics. Continue reading “As Drug Development Costs Skyrocket, AI Offers Some Hope” »

Managing Data and the Digital Revolution with Emerging Technologies

Posted on November 13th, 2017 by in Pharma R&D

The scholarly publishing industry has experienced major shifts in the last few decades. Research journals have long captured the insights of scientific research, further fueling the work of other scientists. Continue reading “Managing Data and the Digital Revolution with Emerging Technologies” »

  1. 1
  2. 2